Top

Published in:

01-04-2018 | Epidemiology

Associations between ALDH1A1 polymorphisms, alcohol consumption, and mortality among Hispanic and non-Hispanic white women diagnosed with breast cancer: the Breast Cancer Health Disparities Study

Authors: Zhiyu Xia, Kathy B. Baumgartner, Richard N. Baumgartner, Stephanie D. Boone, Lisa M. Hines, Esther M. John, Roger Wolff, Martha L. Slattery, Avonne E. Connor

Published in: Breast Cancer Research and Treatment | Issue 2/2018

Abstract

Purpose

ALDH1A1, one of the main isotopes of aldehyde dehydrogenase-1 is involved in the differentiation and protection of normal hematopoietic stem cells and functions in alcohol sensitivity and dependence. We evaluated the associations between ALDH1A1 polymorphisms, alcohol consumption, and mortality among Hispanic and non-Hispanic white (NHW) breast cancer (BC) cases from the Breast Cancer Health Disparities Study.

Methods

Nine SNPs in ALDH1A1 were evaluated in 920 Hispanic and 1372 NHW women diagnosed with incident invasive BC. Adjusted Cox proportional hazard regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Models were stratified by Native American (NA) ancestry and alcohol consumption.

Results

A total of 443 deaths occurred over a median follow-up time of 11 years. After adjusting all results for multiple comparisons, rs7027604 was significantly associated with all-cause mortality (HR_AA = 1.40; 95% CI 1.13–1.73, P _adj = 0.018). The rs1424482 CC genotype (HR_CC = 1.69; 95% CI 1.20–2.37, P _adj = 0.027) and the rs7027604 AA genotype (HR_AA = 1.65; 95% CI 1.21–2.26, P _adj = 0.018) were positively associated with non-BC mortality. Among long-term light drinkers, rs1888202 was associated with decreased all-cause mortality (HR_CG/GG = 0.36; 95% CI 0.20–0.64), while associations were not significant among non-drinkers or moderate/heavy drinkers (P _interation = 0.218). The increased risk of all-cause mortality associated with rs63319 was limited to women with low NA ancestry (HR_AA = 1.53; 95% CI 1.19–1.97).

Conclusions

Multiple SNPs in ALDH1A1 were associated with increased risk of mortality after BC. Future BC studies examining the relationship between ALDH1A1 and mortality should consider the modifying effects of alcohol consumption and NA ancestry.

Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65(1):5–29. https://doi.org/10.3322/caac.21254 CrossRefPubMed

Yang X, Lippman ME (1999) BRCA1 and BRCA2 in breast cancer. Breast Cancer Res Treat 54(1):1–10CrossRefPubMed

Kelsey JL, Gammon MD, John EM (1993) Reproductive factors and breast cancer. Epidemiol Rev 15(1):36–47CrossRefPubMed

Singletary KW, Gapstur SM (2001) Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA 286(17):2143–2151CrossRefPubMed

Howe GR, Hirohata T, Hislop TG, Iscovich JM, Yuan JM, Katsouyanni K, Lubin F, Marubini E, Modan B, Rohan T et al (1990) Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J Natl Cancer Inst 82(7):561–569CrossRefPubMed

Siegel RL, Fedewa SA, Miller KD, Goding-Sauer A, Pinheiro PS, Martinez-Tyson D, Jemal A (2015) Cancer statistics for Hispanics/Latinos, 2015. CA Cancer J Clin. https://doi.org/10.3322/caac.21314

White-Means S, Rice M, Dapremont J, Davis B, Martin J (2015) African American women: Surviving breast cancer mortality against the highest odds. Int J Environ Res Public Health 13(1):ijerph13010006. https://doi.org/10.3390/ijerph13010006 PubMed

Newman LA, Mason J, Cote D, Vin Y, Carolin K, Bouwman D, Colditz GA (2002) African–American ethnicity, socioeconomic status, and breast cancer survival: a meta-analysis of 14 studies involving over 10,000 African–American and 40,000 White American patients with carcinoma of the breast. Cancer 94(11):2844–2854. https://doi.org/10.1002/cncr.10575 CrossRefPubMed

Reis LAG, Eisner MP, Kosary CL et al (2000) SEER cancer statistics review, 1973–1997. Cancer Institute, Bethesda

10.

Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, Dolan NC, Paskett ED, McTiernan A, Hubbell FA, Adams-Campbell LL, Prentice R (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97(6):439–448. https://doi.org/10.1093/jnci/dji064 CrossRefPubMed

11.

Malone KE, Daling JR, Doody DR, Hsu L, Bernstein L, Coates RJ, Marchbanks PA, Simon MS, McDonald JA, Norman SA, Strom BL, Burkman RT, Ursin G, Deapen D, Weiss LK, Folger S, Madeoy JJ, Friedrichsen DM, Suter NM, Humphrey MC, Spirtas R, Ostrander EA (2006) Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res 66(16):8297–8308. https://doi.org/10.1158/0008-5472.CAN-06-0503 CrossRefPubMed

12.

Kurian AW (2010) BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications. Curr Opin Obstet Gynecol 22(1):72–78. https://doi.org/10.1097/GCO.0b013e328332dca3 CrossRefPubMed

13.

Spence JP, Liang T, Eriksson CJ, Taylor RE, Wall TL, Ehlers CL, Carr LG (2003) Evaluation of aldehyde dehydrogenase 1 promoter polymorphisms identified in human populations. Alcohol Clin Exp Res 27(9):1389–1394. https://doi.org/10.1097/01.ALC.0000087086.50089.59 CrossRefPubMedPubMedCentral

14.

Yoshida A, Dave V, Ward RJ, Peters TJ (1989) Cytosolic aldehyde dehydrogenase (ALDH1) variants found in alcohol flushers. Ann Hum Genet 53(Pt 1):1–7CrossRefPubMed

15.

Quertemont E (2004) Genetic polymorphism in ethanol metabolism: acetaldehyde contribution to alcohol abuse and alcoholism. Mol Psychiatry 9(6):570–581. https://doi.org/10.1038/sj.mp.4001497 CrossRefPubMed

16.

Druesne-Pecollo N, Tehard B, Mallet Y, Gerber M, Norat T, Hercberg S, Latino-Martel P (2009) Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer. Lancet Oncol 10(2):173–180. https://doi.org/10.1016/S1470-2045(09)70019-1 CrossRefPubMed

17.

Silva IA, Bai S, McLean K, Yang K, Griffith K, Thomas D, Ginestier C, Johnston C, Kueck A, Reynolds RK, Wicha MS, Buckanovich RJ (2011) Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res 71(11):3991–4001. https://doi.org/10.1158/0008-5472.CAN-10-3175 CrossRefPubMedPubMedCentral

18.

Li T, Su Y, Mei Y, Leng Q, Leng B, Liu Z, Stass SA, Jiang F (2010) ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients’ outcome. Lab Invest 90(2):234–244. https://doi.org/10.1038/labinvest.2009.127 CrossRefPubMed

19.

Patel M, Lu L, Zander DS, Sreerama L, Coco D, Moreb JS (2008) ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors. Lung Cancer 59(3):340–349. https://doi.org/10.1016/j.lungcan.2007.08.033 CrossRefPubMed

20.

Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1(5):555–567. https://doi.org/10.1016/j.stem.2007.08.014 CrossRefPubMedPubMedCentral

21.

Zhong Y, Lin Y, Shen S, Zhou Y, Mao F, Guan J, Sun Q (2013) Expression of ALDH1 in breast invasive ductal carcinoma: an independent predictor of early tumor relapse. Cancer Cell Int 13(1):60. https://doi.org/10.1186/1475-2867-13-60 CrossRefPubMedPubMedCentral

22.

Zhong Y, Shen S, Zhou Y, Mao F, Guan J, Lin Y, Xu Y, Sun Q (2014) ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24− phenotype. Med Oncol 31(3):864. https://doi.org/10.1007/s12032-014-0864-0 CrossRefPubMed

23.

Charafe-Jauffret E, Ginestier C, Iovino F, Tarpin C, Diebel M, Esterni B, Houvenaeghel G, Extra JM, Bertucci F, Jacquemier J, Xerri L, Dontu G, Stassi G, Xiao Y, Barsky SH, Birnbaum D, Viens P, Wicha MS (2010) Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res 16(1):45–55. https://doi.org/10.1158/1078-0432.CCR-09-1630 CrossRefPubMed

24.

Yao S, Sucheston LE, Zhao H, Barlow WE, Zirpoli G, Liu S, Moore HC, Thomas Budd G, Hershman DL, Davis W, Ciupak GL, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Livingston RB, Albain KS, Hayes DF, Ambrosone CB (2014) Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer. Pharmacogenomics J 14(3):241–247. https://doi.org/10.1038/tpj.2013.32 CrossRefPubMed

25.

Slattery ML, John EM, Torres-Mejia G, Lundgreen A, Herrick JS, Baumgartner KB, Hines LM, Stern MC, Wolff RK (2012) Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population. Carcinogenesis 33(8):1512–1521. https://doi.org/10.1093/carcin/bgs163 CrossRefPubMedPubMedCentral

26.

Slattery ML, Sweeney C, Edwards S, Herrick J, Baumgartner K, Wolff R, Murtaugh M, Baumgartner R, Giuliano A, Byers T (2007) Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women. Breast Cancer Res Treat 102(1):85–101. https://doi.org/10.1007/s10549-006-9292-y CrossRefPubMed

27.

John EM, Phipps AI, Davis A, Koo J (2005) Migration history, acculturation, and breast cancer risk in Hispanic women. Cancer Epidemiol Biomark Prev 14(12):2905–2913. https://doi.org/10.1158/1055-9965.EPI-05-0483 CrossRef

28.

Slattery ML, John EM, Torres-Mejia G, Lundgreen A, Lewinger JP, Stern MC, Hines L, Baumgartner KB, Giuliano AR, Wolff RK (2014) Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study. Int J Cancer 134(3):629–644. https://doi.org/10.1002/ijc.28377 CrossRefPubMed

29.

Falush D, Stephens M, Pritchard JK (2003) Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 164(4):1567–1587PubMedPubMedCentral

30.

Pritchard JK, Stephens M, Donnelly P (2000) Inference of population structure using multilocus genotype data. Genetics 155(2):945–959PubMedPubMedCentral

31.

Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263–265. https://doi.org/10.1093/bioinformatics/bth457 CrossRefPubMed

32.

Westfall PH, Randall TD, Rom D, Wolfinger RD, Hochberg Y (1999) Multiple comparisons and multiple tests using SAS. SAS Institute Inc., Cary

33.

Liu J, Zhou Z, Hodgkinson CA, Yuan Q, Shen PH, Mulligan CJ, Wang A, Gray RR, Roy A, Virkkunen M, Goldman D, Enoch MA (2011) Haplotype-based study of the association of alcohol-metabolizing genes with alcohol dependence in four independent populations. Alcohol Clin Exp Res 35(2):304–316. https://doi.org/10.1111/j.1530-0277.2010.01346.x CrossRefPubMed

34.

Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA (2011) Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ 342:d671. https://doi.org/10.1136/bmj.d671 CrossRefPubMedPubMedCentral

35.

Friedman LA, Kimball AW (1986) Coronary heart disease mortality and alcohol consumption in Framingham. Am J Epidemiol 124(3):481–489CrossRefPubMed

Title: Associations between ALDH1A1 polymorphisms, alcohol consumption, and mortality among Hispanic and non-Hispanic white women diagnosed with breast cancer: the Breast Cancer Health Disparities Study
Authors: Zhiyu Xia
Kathy B. Baumgartner
Richard N. Baumgartner
Stephanie D. Boone
Lisa M. Hines
Esther M. John
Roger Wolff
Martha L. Slattery
Avonne E. Connor
Publication date: 01-04-2018
Publisher: Springer US
Published in: Breast Cancer Research and Treatment / Issue 2/2018
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-017-4600-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2018

Efficacy of palbociclib plus fulvestrant after everolimus in hormone receptor-positive metastatic breast cancer

Trends in progression-free survival (PFS) and time to progression (TTP) over time within first-line aromatase inhibitors trials in hormone receptor-positive advanced breast cancer

Characterization of a novel germline BRCA1 splice variant, c.5332+4delA

CD14+ HLA-DR−/low MDSCs are elevated in the periphery of early-stage breast cancer patients and suppress autologous T cell proliferation

Worse survival after breast cancer in women with anorexia nervosa

Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition

Keynote webinar | Spotlight on antibody–drug conjugates in cancer